Evidence map›Paper›PMID 40391359›Full record

ArticleRSC advances2025

New spirooxindole pyrrolidine/pyrrolizidine analogs: design, synthesis, and evaluation as an anticancer agent.

Narayanasamy Nivetha, Janarthanan Venkatesan, Dhanashree Murugan, Loganathan Rangasamy, Shu Pao Wu, Sivan Velmathi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Narayanasamy NivethaOrganic and Polymer Synthesis Laboratory, Department of Chemistry, National Institute of Technology Tiruchirappalli 620015 Tamil Nadu India velmathis@nitt.edu.
Janarthanan VenkatesanDrug Discovery Unit, Centre for Biomaterials, Cellular and Molecular Theragnostic (CBCMT), Vellore Institute of Technology Vellore 632014 Tamil Nadu India.
Dhanashree MuruganDrug Discovery Unit, Centre for Biomaterials, Cellular and Molecular Theragnostic (CBCMT), Vellore Institute of Technology Vellore 632014 Tamil Nadu India.
Loganathan RangasamyDrug Discovery Unit, Centre for Biomaterials, Cellular and Molecular Theragnostic (CBCMT), Vellore Institute of Technology Vellore 632014 Tamil Nadu India.ORCID https://orcid.org/0000-0002-1339-0330
Shu Pao WuDepartment of Applied Chemistry, National Yang Ming Chiao Tung University Hsinchu 30010 Taiwan Republic of China.
Sivan VelmathiOrganic and Polymer Synthesis Laboratory, Department of Chemistry, National Institute of Technology Tiruchirappalli 620015 Tamil Nadu India velmathis@nitt.edu.ORCID https://orcid.org/0000-0001-7303-0698

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel series of mesitylene-based spirooxindoles were synthesized

Identifiers

PMID40391359
PMCPMC12086819

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.